2017/2 GaBI Journal Table of Contents

Contents

Editor’s Letter

What to look forward to in GaBI Journal, 2017, Issue 2

Editorial

Trends and challenges in biosimilars pricing and reimbursement policies in Europe and beyond

Commentary

Strategies for pricing of pharmaceuticals and generics in developing countries

Original Research

What pricing and reimbursement policies to use for off-patent biologicals in Europe? – results from the second EBE biological medicines policy survey

Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey

Special Report

Overview of the patent expiry of (non-)tyrosine kinase inhibitors approved for clinical use in the EU and the US

Interchangeability of biosimilars in the US and around the world

Abstracted Scientific Content

Generic prices estimated for four novel cancer drugs

Effective generics substitution

Source URL: https://gabi-journal.net/20172-gabi-journal-table-of-contents.html